Paul Howe, chief commercial officer at Protega, discusses efforts to combine high tech solutions with pain-management medications.
Using Digital Therapeutics with Abuse-Deterrent Pain Medication
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours